Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03792841
Title Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 160 in Subjects With mCRPC
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NLD | FRA | CAN | BEL | AUT | AUS


No variant requirements are available.